Orgenesis’ Acquisition Of Tamir Biotechnology, Inc. Assets

Pearl Cohen represented Orgenesis in the deal, while Fenwick & West represented Tamir Biotechnology. Orgenesis acquired the assets of Tamir Biotechnology, Inc. (“TamirBio”), including ranpirnase, TamirBio’s…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now